Main Content

Latest News


All numbers expressed in millions of dollars, except per share amounts and as otherwise indicated. 

Q2 2019 highlights (compared to Q2 2018)

  • Common shareholders’ net income of $20 compared to $57

  • Earnings per share (basic and diluted) of $20.45 compared to $58.14

  • Return on common shareholders’ equity1 (“ROE”) of 5.1% compared to 15.6%


(Kingston, ON – August 1, 2019) – The Board of Directors of The Empire Life Insurance Company (Empire Life) (TSX: EML.PR.A) today declared the following cash dividends:


Record Date

Payable Date

Amount of Dividend

Common Shares

August 19, 2019


(Toronto, ON – April 3, 2017) – Empire Life Investments Inc. today announced the appointment of Douglas Cooper, CFA, as Portfolio Manager, Canadian Equities, to the Empire Life Investments team.


(Toronto, Ontario, March 1, 2017) The Empire Life Insurance Company (Empire Life) (TSX: EML.PR.A.) announced today it will make its specialty drug program a standard feature in all Group drug plans it offers. The specialty drug program, part of the Empire Life Actively Managed Drug Solutions portfolio, will be included in new customers’ plans starting June 1, 2017. Current customers will join the program when their policies renew.


(Kingston, ON – February 24, 2017) – The Empire Life Insurance Company (Empire Life) (TSX: EML.PR.A) has declared a cash dividend on the Non-Cumulative Rate Reset Preferred Shares, Series 1, being $0.359375 per share to be paid on April 17, 2017 to shareholders of record March 17, 2017.